Hawaii said on Friday it entered a $700 million settlement with pharmaceutical firm Bristol-Myers Squibb and units of French ...

Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...

The Department of Attorney General of Hawaii announced that Bristol-Myers Squibb (NYSE:BMY) and three units of Sanofi (NASDAQ ...

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

The settlement divides the $700 million payment equally between pharmaceutical giants Bristol Myers Squibb and Sanofi.

Hawaii will receive $700 million in a landmark settlement from pharmaceutical giants Bristol Myers Squibb and Sanofi following more than a decade of litigation over the blood thinner Plavix and its ...

HONOLULU (HawaiiNewsNow) - The state of Hawaii has entered into a $700 million settlement agreement with pharmaceutical ...

After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...

The settlement concludes a 12-year legal battle over the efficacy of Plavix for Asian, Pacific Islander and Native Hawaiian ...

Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year ...

Moody’s Ratings has upgraded the long-term issuer rating and senior unsecured ratings of Sanofi (NASDAQ:SNY) from A1 to Aa3.

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...